Page 3 - Davidf Hale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davidf hale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davidf Hale Today - Breaking & Trending Today

Oncternal Therapeutics (NASDAQ:ONCT) Price Target Lowered to $1.30 at Cantor Fitzgerald

Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) had its price target trimmed by Cantor Fitzgerald from $4.00 to $1.30 in a research report released on Tuesday, The Fly reports. The brokerage currently has an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Oncternal Therapeutics’ FY2023 earnings at ($0.50) EPS. ONCT has been the […] ....

San Diego , United States , Jamesb Breitmeyer , Davidf Hale , Cantor Fitzgerald , Waypoint Capital Advisors , Oncternal Therapeutics Inc , Millennium Management , Oncternal Therapeutics Company Profile , Ci Private Wealth , Oncternal Therapeutics , Get Rating , Oncternal Therapeutic , Brookline Capital Management , Therapeutics Trading Down , Capital Advisors , Sigma Advisers , Two Sigma Investments , Sigma Investments , Oncternal Therapeutics Daily , Nasdaq Onct , Lower Price Target ,

Oncternal Therapeutics (NASDAQ:ONCT) Given Hold Rating at Brookline Capital Acquisition

Brookline Capital Acquisition restated their hold rating on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research note issued to investors on Tuesday morning, Benzinga reports. Other equities research analysts have also recently issued reports about the company. Maxim Group cut Oncternal Therapeutics from a buy rating to a hold rating in a […] ....

San Diego , United States , Jamesb Breitmeyer , Davidf Hale , Maxim Group , Waypoint Capital Advisors , Goldman Sachs Group Inc , Quantum Private Wealth , Mirabella Financial Services , Oncternal Therapeutics Inc , Prudential Financial Inc , Brookline Capital Acquisition , Oncternal Therapeutics , Get Rating , Brookline Capital Management , Therapeutics Trading Down , Private Wealth , Sachs Group , Financial Services , Oncternal Therapeutics Daily , Nasdaq Onct , Reiterated Rating , Brookline Capital Acquisition Corp ,

Oncternal Therapeutics (NASDAQ:ONCT) Rating Lowered to Market Perform at Oppenheimer

Oppenheimer downgraded shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) from an outperform rating to a market perform rating in a research report released on Tuesday morning, The Fly reports. Oppenheimer also issued estimates for Oncternal Therapeutics’ Q2 2023 earnings at ($0.17) EPS, Q3 2023 earnings at ($0.14) EPS, Q4 2023 earnings at ($0.12) EPS, […] ....

San Diego , United States , Davidf Hale , Jamesb Breitmeyer , Waypoint Capital Advisors , Healthcare Of Ontario Pension Plan Trust Fund , Oncternal Therapeutics Company Profile , Cantor Fitzgerald , Renaissance Technologies , Oncternal Therapeutics Inc , Quantum Private Wealth , Oncternal Therapeutics , Get Rating , Capital Management , Therapeutics Stock Down , Capital Advisors , Private Wealth , Ontario Pension Plan Trust Fund , Two Sigma Investments , Sigma Investments , Oncternal Therapeutics Daily , Nasdaq Onct , Oppenheimer Holdings Inc ,

Brookline Capital Management Lowers Oncternal Therapeutics (NASDAQ:ONCT) to Hold

Brookline Capital Management downgraded shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) from a buy rating to a hold rating in a research note released on Monday, PriceTargets.com reports. Brookline Capital Management also issued estimates for Oncternal Therapeutics’ Q1 2023 earnings at ($0.16) EPS, Q2 2023 earnings at ($0.15) EPS, Q3 2023 earnings at ($0.12) […] ....

San Diego , United States , Davidf Hale , Jamesb Breitmeyer , Oncternal Therapeutics Inc , Cantor Fitzgerald , Healthcare Of Ontario Pension Plan Trust Fund , Mirabella Financial Services , Renaissance Technologies , Vanguard Group Inc , Brookline Capital Management , Oncternal Therapeutics , Get Rating , Capital Management , Brookline Capital Acquisition , Ontario Pension Plan Trust Fund , Financial Services , Oncternal Therapeutics Daily , Nasdaq Onct ,

Oncternal Therapeutics (NASDAQ:ONCT) Downgraded by Maxim Group

Maxim Group downgraded shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) from a buy rating to a hold rating in a report issued on Tuesday morning, The Fly reports. Other equities research analysts have also issued research reports about the company. StockNews.com began coverage on Oncternal Therapeutics in a research report on Thursday, March 16th. […] ....

San Diego , United States , Jamesb Breitmeyer , Davidf Hale , Mirabella Financial Services , Ci Private Wealth , Oncternal Therapeutics Company Profile , Prudential Financial Inc , Waypoint Capital Advisors , Virtu Financial , Cantor Fitzgerald , Maxim Group , Oncternal Therapeutics Inc , Oncternal Therapeutics , Get Rating , Brookline Capital Management , Capital Advisors , Financial Services , Oncternal Therapeutics Daily , Nasdaq Onct ,